Delaware
|
13-4996950
|
(State
or other jurisdiction
|
(I.R.S.
Employer Identification No.)
|
of
incorporation or organization)
|
469
North Harrison Street, Princeton, N.J. 08543-5297
|
(Address
of principal executive office)
|
Large accelerated filer | x | Accelerated filer | o | ||
Non-accelerated filer | o | Smaller reporting company | o |
Item
|
Page
|
|
1.
|
3
|
|
2.
|
23
|
|
3.
|
27
|
|
4.
|
28
|
1.
|
29
|
|
1A.
|
29
|
|
4.
|
29
|
|
6.
|
30
|
Three
Months Ended
|
||||||||
March
28,
|
March
30,
|
|||||||
(Dollars
in thousands, except per share data)
|
2008
|
2007
|
||||||
Net
Sales
|
$ | 552,867 | $ | 514,335 | ||||
Cost
of sales
|
328,761 | 314,459 | ||||||
Gross
Profit
|
224,106 | 199,876 | ||||||
Marketing
expense
|
53,485 | 45,852 | ||||||
Selling,
general and administrative expenses
|
77,859 | 71,881 | ||||||
Income
from Operations
|
92,762 | 82,143 | ||||||
Equity
in earnings of affiliates
|
2,380 | 2,260 | ||||||
Investment
earnings
|
2,569 | 1,633 | ||||||
Other
income (expense), net
|
2,198 | (414 | ) | |||||
Interest
expense
|
(12,505 | ) | (15,201 | ) | ||||
Income
before minority interest and income taxes
|
87,404 | 70,421 | ||||||
Minority
interest
|
2 | (5 | ) | |||||
Income
before income taxes
|
87,402 | 70,426 | ||||||
Income
taxes
|
31,211 | 25,327 | ||||||
Net
Income
|
$ | 56,191 | $ | 45,099 | ||||
Weighted
average shares outstanding - Basic
|
66,343 | 65,570 | ||||||
Weighted
average shares outstanding - Diluted
|
70,817 | 70,024 | ||||||
Net
income per share - Basic
|
$ | 0.85 | $ | 0.69 | ||||
Net
income per share - Diluted
|
$ | 0.81 | $ | 0.66 | ||||
Dividends
Per Share
|
$ | 0.08 | $ | 0.07 |
March
28,
|
December
31,
|
|||||||
(Dollars
in thousands, except share and per share data)
|
2008
|
2007
|
||||||
Assets
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$ | 208,062 | $ | 249,809 | ||||
Accounts
receivable, less allowances of $4,512 and $4,548
|
243,513 | 247,898 | ||||||
Inventories
|
214,966 | 213,651 | ||||||
Deferred
income taxes
|
13,370 | 13,508 | ||||||
Note
receivable – current
|
1,324 | 1,263 | ||||||
Prepaid
expenses
|
11,554 | 9,224 | ||||||
Total
Current Assets
|
692,789 | 735,353 | ||||||
Property,
Plant and Equipment (Net)
|
339,808 | 350,853 | ||||||
Note
Receivable
|
2,342 | 3,670 | ||||||
Equity
Investment in Affiliates
|
9,563 | 10,324 | ||||||
Long-term
Supply Contracts
|
2,323 | 2,519 | ||||||
Tradenames
and Other Intangibles
|
657,464 | 665,168 | ||||||
Goodwill
|
688,128 | 688,842 | ||||||
Other
Assets
|
72,866 | 75,761 | ||||||
Total
Assets
|
$ | 2,465,283 | $ | 2,532,490 | ||||
Liabilities
and Stockholders' Equity
|
||||||||
Current
Liabilities
|
||||||||
Short-term
borrowings
|
$ | 15,293 | $ | 115,000 | ||||
Accounts
payable and accrued expenses
|
269,958 | 303,071 | ||||||
Current
portion of long-term debt
|
39,582 | 33,706 | ||||||
Income
taxes payable
|
24,561 | 6,012 | ||||||
Total
Current Liabilities
|
349,394 | 457,789 | ||||||
Long-term
Debt
|
692,982 | 707,311 | ||||||
Deferred
Income Taxes
|
161,152 | 162,746 | ||||||
Other
Long Term Liabilities
|
93,515 | 87,769 | ||||||
Pension,
Postretirement and Postemployment Benefits
|
34,716 | 36,416 | ||||||
Minority
Interest
|
196 | 194 | ||||||
Total
Liabilities
|
1,331,955 | 1,452,225 | ||||||
Commitments
and Contingencies
|
||||||||
Stockholders'
Equity
|
||||||||
Preferred
Stock-$1.00 par value
|
||||||||
Authorized
2,500,000 shares, none issued
|
- | - | ||||||
Common
Stock-$1.00 par value
|
||||||||
Authorized
150,000,000 shares, issued 69,991,482 shares
|
69,991 | 69,991 | ||||||
Additional
paid-in capital
|
127,812 | 121,902 | ||||||
Retained
earnings
|
942,752 | 891,868 | ||||||
Accumulated
other comprehensive income
|
33,923 | 39,128 | ||||||
1,174,478 | 1,122,889 | |||||||
Common
stock in treasury, at cost:
|
||||||||
3,579,010
shares in 2008 and 3,747,719 shares in 2007
|
(41,150 | ) | (42,624 | ) | ||||
Total
Stockholders’ Equity
|
1,133,328 | 1,080,265 | ||||||
Total
Liabilities and Stockholders’ Equity
|
$ | 2,465,283 | $ | 2,532,490 |
Three
Months Ended
|
||||||||
March
28,
|
March
30,
|
|||||||
(Dollars
in thousands)
|
2008
|
2007
|
||||||
Cash
Flow From Operating Activities
|
||||||||
Net
Income
|
$ | 56,191 | $ | 45,099 | ||||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||
Depreciation
and amortization
|
15,212 | 14,614 | ||||||
Equity
in earnings of affiliates
|
(2,380 | ) | (2,260 | ) | ||||
Distributions
from unconsolidated affiliates
|
2,564 | 1,461 | ||||||
Deferred
income taxes
|
2,103 | 4,096 | ||||||
Gain
on sale of subsidiary
|
(3,005 | ) | - | |||||
Asset
impairment charges and other asset write-offs
|
5,626 | 595 | ||||||
Non
cash compensation expense
|
2,424 | 2,819 | ||||||
Unrealized
foreign exchange gain and other
|
(2,558 | ) | 176 | |||||
Change
in assets and liabilities:
|
||||||||
Accounts
receivable
|
3,436 | 2,183 | ||||||
Inventories
|
(3,549 | ) | (20,176 | ) | ||||
Prepaid
expenses
|
(2,409 | ) | (2,217 | ) | ||||
Accounts
payable and accrued expenses
|
(30,473 | ) | (30,556 | ) | ||||
Income
taxes payable
|
20,936 | 14,546 | ||||||
Excess
tax benefit on stock options exercised
|
(1,872 | ) | (3,837 | ) | ||||
Other
liabilities
|
477 | 3,057 | ||||||
Net
Cash Provided By Operating Activities
|
62,723 | 29,600 | ||||||
Cash
Flow From Investing Activities
|
||||||||
Additions
to property, plant and equipment
|
(6,283 | ) | (11,294 | ) | ||||
Proceeds
from sale of subsidiary
|
9,620 | - | ||||||
Acquisitions
(net of cash acquired)
|
- | (181 | ) | |||||
Return
of capital from equity affiliates
|
- | 150 | ||||||
Proceeds
from note receivable
|
1,263 | - | ||||||
Contingent
acquisition payments
|
(305 | ) | (370 | ) | ||||
Other
|
(111 | ) | 152 | |||||
Net
Cash Provided by (Used In) Investing Activities
|
4,184 | (11,543 | ) | |||||
Cash
Flow From Financing Activities
|
||||||||
Long-term
debt repayment
|
(8,453 | ) | (39,537 | ) | ||||
Short-term
debt (repayments) borrowings - net
|
(100,000 | ) | 15,011 | |||||
Bank
overdrafts
|
293 | (1,939 | ) | |||||
Proceeds
from stock options exercised
|
2,761 | 6,445 | ||||||
Excess
tax benefit on stock options exercised
|
1,872 | 3,837 | ||||||
Payment
of cash dividends
|
(5,307 | ) | (4,584 | ) | ||||
Net
Cash Used In Financing Activities
|
(108,834 | ) | (20,767 | ) | ||||
Effect
of exchange rate changes on cash and cash equivalents
|
180 | (28 | ) | |||||
Net
Change in Cash and Cash Equivalents
|
(41,747 | ) | (2,738 | ) | ||||
Cash
and Cash Equivalents at Beginning Of Period
|
249,809 | 110,476 | ||||||
Cash
and Cash Equivalents at End Of Period
|
$ | 208,062 | $ | 107,738 |
Three
Months Ended
|
||||||||
SUPPLEMENTAL
CASH FLOW INFORMATION
|
March
28,
|
March
30,
|
||||||
(Dollars
in thousands)
|
2008
|
2007
|
||||||
Cash
paid during the three months for:
|
||||||||
Interest
(net of amounts capitalized)
|
$ | 9,270 | $ | 12,424 | ||||
Income
taxes (net of refunds)
|
$ | 7,584 | $ | 4,369 | ||||
Supplemental
disclosure of non-cash investing activities:
|
||||||||
Property,
plant and equipment expenditures included in Accounts
Payable
|
$ | 932 | $ | 686 |
Number
of Shares
|
Amounts
|
|||||||||||||||||||||||||||||||
(In
thousands)
|
Common
Stock
|
Treasury
Stock
|
Common
Stock
|
Treasury
Stock
|
Additional
Paid-In Capital
|
Retained
Earnings
|
Accumulated
Other Comprehensive Income (Loss)
|
Comprehensive
Income
|
||||||||||||||||||||||||
December
31, 2007
|
69,991 | (3,748 | ) | $ | 69,991 | $ | (42,624 | ) | $ | 121,902 | $ | 891,868 | $ | 39,128 | ||||||||||||||||||
Net
income
|
- | - | - | - | - | 56,191 | - | $ | 56,191 | |||||||||||||||||||||||
Translation
adjustments
|
- | - | - | - | - | - | (2,880 | ) | (2,880 | ) | ||||||||||||||||||||||
Interest
rate agreements (net of taxes)
|
- | - | - | - | - | - | (2,325 | ) | (2,325 | ) | ||||||||||||||||||||||
Comprehensive
income
|
- | - | - | - | - | - | - | $ | 50,986 | |||||||||||||||||||||||
Cash
dividends
|
- | - | - | - | - | (5,307 | ) | - | ||||||||||||||||||||||||
Stock
based compensation expense
|
||||||||||||||||||||||||||||||||
and
stock option plan
|
||||||||||||||||||||||||||||||||
transactions
(including tax benefit)
|
- | 163 | - | 1,423 | 5,790 | - | - | |||||||||||||||||||||||||
Stock
purchases
|
- | - | - | - | - | - | - | |||||||||||||||||||||||||
Other
stock issuances
|
- | 6 | - | 51 | 120 | - | - | |||||||||||||||||||||||||
March
28, 2008
|
69,991 | (3,579 | ) | $ | 69,991 | $ | (41,150 | ) | $ | 127,812 | $ | 942,752 | $ | 33,923 |
1.
|
Basis
of Presentation
|
2.
|
Recently
Adopted Accounting Pronouncements
|
March
28, 2008
|
||||||||||||||||
(In thousands) |
Carrying Amount |
Quoted
Prices in Active
Markets |
Significant
Other Observable
Inputs |
Significant Unobservable
Inputs |
||||||||||||
Assets
|
||||||||||||||||
Deferred compensation related investments
|
$ | 32,175 | $ | - | $ | 32,175 | $ | - | ||||||||
Diesel
hedge contract
|
1,936 | - | 1,936 | - | ||||||||||||
$ | 34,111 | $ | - | $ | 34,111 | $ | - | |||||||||
Liabilities
|
||||||||||||||||
Interest
rate collars
|
$ | 5,767 | $ | - | $ | 5,767 | $ | - | ||||||||
Deferred
compensation liability
|
48,543 | 15,006 | 33,537 | - | ||||||||||||
$ | 54,310 | $ | 15,006 | $ | 39,304 | $ | - |
3.
|
Inventories
consist of the following:
|
March
28,
|
December
31,
|
|||||||
(In
thousands)
|
2008
|
2007
|
||||||
Raw
materials and supplies
|
$ | 51,009 | $ | 53,516 | ||||
Work
in process
|
9,308 | 9,169 | ||||||
Finished
goods
|
154,649 | 150,966 | ||||||
$ | 214,966 | $ | 213,651 |
4.
|
Property,
Plant and Equipment consist of the
following:
|
March
28,
|
December
31,
|
|||||||
(In
thousands)
|
2008
|
2007
|
||||||
Land
|
$ | 11,069 | $ | 11,343 | ||||
Buildings
and improvements
|
145,167 | 147,114 | ||||||
Machinery
and equipment
|
423,746 | 436,104 | ||||||
Office
equipment and other assets
|
38,792 | 40,380 | ||||||
Software
|
32,504 | 33,336 | ||||||
Mineral
rights
|
1,521 | 1,490 | ||||||
Construction
in progress
|
18,841 | 15,915 | ||||||
671,640 | 685,682 | |||||||
Less
accumulated depreciation and amortization
|
331,832 | 334,829 | ||||||
Net
Property, Plant and Equipment
|
$ | 339,808 | $ | 350,853 |
5.
|
Earnings
Per Share
|
Three
Months Ended
|
||||||||
(In
thousands)
|
March
28,
2008
|
March
30,
2007
|
||||||
Basic
|
66,343 | 65,570 | ||||||
Dilutive
effect of stock options
|
1,240 | 1,228 | ||||||
Dilutive
effect of convertible debentures
|
3,234 | 3,226 | ||||||
Diluted
|
70,817 | 70,024 | ||||||
Anti-dilutive
stock options outstanding - not included in the calculation of
earnings
per share
|
490 | 108 |
6.
|
Stock-Based
Compensation
|
Options
(000)
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Contractual Term
|
Aggregate
Intrinsic Values
($000)
|
|||||||||||||
Outstanding
at January 1, 2008
|
4,231 | $ | 30.24 | |||||||||||||
Granted
|
10 | 52.37 | ||||||||||||||
Exercised
|
(163 | ) | 16.59 | |||||||||||||
Cancelled
|
(20 | ) | 33.99 | |||||||||||||
Outstanding at March 28, 2008 | 4,058 | $ | 30.81 |
6.2
|
$ | 90,343 | ||||||||||
Exercisable
at March 28, 2008
|
1,982 | $ | 21.95 | 4.3 | $ | 61,677 |
Three
Months Ended
|
||||||||
March
28,
2008
|
March
30,
2007
|
|||||||
Intrinsic
Value of Stock Options Exercised (in millions)
|
$ | 6.0 | $ | 12.3 | ||||
Stock
Compensation Expense Related To Stock Option Awards (in
millions)
|
$ | 2.3 | $ | 2.8 | ||||
Issued
Stock Options (in thousands)
|
10 | -- | ||||||
Average
Fair Value of Stock Options Issued
|
$ | 16.12 | $ | -- | ||||
Assumptions
Used:
|
||||||||
Risk-free
interest rate
|
3.9 | % | -- | |||||
Expected
life in Years
|
6.5 | -- | ||||||
Expected
volatility
|
23.4 | % | -- |
7.
|
Goodwill
and Other Intangible Assets
|
(In thousands) |
March
28, 2008
|
December
31, 2007
|
||||||||||||||||||||||
|
Gross Carrying |
Accumulated Amortization |
Net
|
Gross Carrying |
Accumulated Amortization |
Net
|
||||||||||||||||||
Amortizable intangible
assets:
|
||||||||||||||||||||||||
Tradenames
|
$ | 121,577 | $ | (31,172 | ) | $ | 90,405 | $ | 107,066 | $ | (31,154 | ) | $ | 75,912 | ||||||||||
Customer
Relationships
|
130,747 | (15,669 | ) | 115,078 | 131,366 | (13,758 | ) | 117,608 | ||||||||||||||||
Patents/Formulas
|
27,220 | (12,606 | ) | 14,614 | 27,220 | (11,816 | ) | 15,404 | ||||||||||||||||
Non
Compete Agreement
|
1,143 | (723 | ) | 420 | 1,143 | (695 | ) | 448 | ||||||||||||||||
Total
|
$ | 280,687 | $ | (60,170 | ) | $ | 220,517 | $ | 266,795 | $ | (57,423 | ) | $ | 209,372 | ||||||||||
Unamortizable
intangible assets - carrying value
|
||||||||||||||||||||||||
Tradenames
|
$ | 436,947 | $ | 455,796 |
Consumer
|
Consumer
|
|||||||||||||||
(In
thousands)
|
Domestic
|
International
|
SPD
|
Total
|
||||||||||||
Balance
December 31, 2007
|
$ | 633,030 | $ | 33,224 | $ | 22,588 | $ | 688,842 | ||||||||
Subsidiary
Divestiture
|
- | - | (971 | ) | (971 | ) | ||||||||||
Additional
Unilever contingent consideration
|
257 | - | - | 257 | ||||||||||||
Balance
March 28, 2008
|
$ | 633,287 | $ | 33,224 | $ | 21,617 | $ | 688,128 |
8.
|
Short-term
Borrowings and Long-Term Debt
|
March
28,
|
December
31,
|
|||||||||||
(In
thousands)
|
2008
|
2007
|
||||||||||
Short-term borrowings
|
||||||||||||
Securitization
of accounts receivable
|
$ | 15,000 | $ | 115,000 | ||||||||
Bank
overdraft debt
|
293 | - | ||||||||||
Total
short-term borrowings
|
$ | 15,293 | $ | 115,000 | ||||||||
Long-term debt
|
||||||||||||
Term
Loan facility
|
$ | 382,642 | $ | 391,069 | ||||||||
Amount
due 2008
|
$ | 25,279 | ||||||||||
Amount
due 2009
|
$ | 57,211 | ||||||||||
Amount
due 2010
|
$ | 149,680 | ||||||||||
Amount
due 2011
|
$ | 66,310 | ||||||||||
Amount
due 2012
|
$ | 84,162 | ||||||||||
Convertible
debentures due on August 15, 2033
|
99,922 | 99,948 | ||||||||||
Senior
subordinated notes (6%) due December 22, 2012
|
250,000 | 250,000 | ||||||||||
Total
long-term debt
|
732,564 | 741,017 | ||||||||||
Less:
current maturities
|
39,582 | 33,706 | ||||||||||
Net
long-term debt
|
$ | 692,982 | $ | 707,311 |
(In thousands) | ||||||||
Due
by March 31, 2009
|
$ |
39,582
|
||||||
Due
by March 31, 2010
|
77,778 | |||||||
Due
by March 31, 2011
|
127,563 | |||||||
Due
by March 31, 2012
|
81,612 | |||||||
Due
by March 31, 2013
|
306,107 | |||||||
Due
March 31, 2014 and subsequent
|
99,922 | |||||||
$ | 732,564 |
9.
|
Comprehensive
Income
|
Three
Months Ended
|
||||||||
March
28,
|
March
30,
|
|||||||
(In
thousands)
|
2008
|
2007
|
||||||
Net
Income
|
$ | 56,191 | $ | 45,099 | ||||
Other
Comprehensive Income, Net of Tax:
|
||||||||
Foreign
Exchange Translation Adjustments (Net of Divestiture)
|
(2,880 | ) | 1,052 | |||||
Interest
Rate Hedge Agreements
|
(2,325 | ) | (73 | ) | ||||
Comprehensive
Income
|
$ | 50,986 | $ | 46,078 |
10.
|
Pension
and Postretirement Plans
|
Pension
Costs
|
||||||||
Three
Months Ended
|
||||||||
March
28,
|
March
30,
|
|||||||
(In
thousands)
|
2008
|
2007
|
||||||
Components
of Net Periodic Benefit Cost:
|
||||||||
Service
cost
|
$ | 723 | $ | 626 | ||||
Interest
cost
|
1,937 | 1,708 | ||||||
Expected
return on plan assets
|
(2,179 | ) | (1,856 | ) | ||||
Amortization
of prior service cost
|
4 | 3 | ||||||
Recognized
actuarial loss
|
(9 | ) | 51 | |||||
Net
periodic benefit cost
|
$ | 476 | $ | 532 | ||||
Postretirement
Costs
|
||||||||
Three
Months Ended
|
||||||||
March
28,
|
March
30,
|
|||||||
(In
thousands)
|
2008
|
2007
|
||||||
Components
of Net Periodic Benefit Cost:
|
||||||||
Service
cost
|
$ | 187 | $ | 182 | ||||
Interest
cost
|
367 | 354 | ||||||
Amortization
of prior service cost
|
11 | 10 | ||||||
Recognized
actuarial loss
|
- | 5 | ||||||
Net
periodic benefit cost
|
$ | 565 | $ | 551 |
11.
|
Commitments,
contingencies and guarantees
|
a.
|
The
Company has a partnership with a supplier of raw materials which mines and
processes sodium mineral deposits. This agreement
terminates upon two years’ written notice by either
company. The Company has an annual commitment to purchase
240,000 tons at the prevailing market price and purchases the majority of
its sodium raw material requirements from the partnership. The
Company is not engaged in any other material transactions with the
partnership or the Company’s
partner.
|
b.
|
The
Company’s distribution of condoms under the TROJAN and other trademarks is
regulated by the U.S. Food and Drug Administration (FDA). Certain of the
Company’s condoms and similar condoms sold by its competitors contain the
spermicide nonoxynol-9 (N-9). The World Health Organization and other
interested groups have issued reports suggesting that N-9 should not be
used rectally or for multiple daily acts of vaginal intercourse, given the
ingredient’s potential to cause irritation to human membranes. In 2005,
the FDA issued non-binding draft guidance concerning the labeling of
condoms in general and those with N-9 in particular. The Company filed a
response recommending alternative labeling to the FDA and has engaged in
further discussions with the FDA since that time. While awaiting further
FDA guidance, the Company implemented an interim label statement change
cautioning against rectal use and more-than-once-a-day vaginal use of
condoms with N-9 and launched a public information campaign to communicate
these messages to the affected communities. The Company believes that its
present labeling for condoms with N-9 is compliant with the overall
objectives of the FDA’s draft guidance and that condoms with N-9 will
remain a viable contraceptive choice for those couples who wish to use
them. The Company cannot predict the nature of the labeling that
ultimately will be required by the FDA if the FDA or state governments
eventually promulgate rules which prohibit or restrict the use of N-9 in
condoms (such as new labeling requirements). The Company could
incur costs from obsolete products, packaging or raw materials, and sales
of condoms could decline, which, in turn, could decrease the Company’s
operating income.
|
c.
|
As
of March 28, 2008, the Company has commitments to acquire approximately
$99.9 million of raw material, packaging supplies and services from its
vendors at market prices.
|
d.
|
The
Company has $6.0 million of outstanding letters of credit drawn on several
banks which guarantee payment for such things as finished goods inventory,
insurance claims and one year of rent on a warehouse in the event of the
Company’s insolvency.
|
e.
|
In
connection with the Company’s October 2003 acquisition of Unilever’s oral
care brands in the United States and Canada in October 2003, the Company
is required to make additional performance-based payments of a minimum of
$5.0 million and a maximum of $12.0 million over the eight year period
following the acquisition. The Company made cash payments of
$0.3 million, and accrued a payment of $0.3 million in the first three
months of 2008. The payment and accrual were accounted for as
additional purchase price. The Company has paid approximately
$8.3 million, exclusive of the $0.3 million accrual, in additional
performance-based payments since the
acquisition.
|
f.
|
The
Company filed suit against Abbott Laboratories, Inc (“Abbott”) in April
2005 claiming infringement of certain patents resulting from Abbott’s
manufacture and sale of its Fact Plus pregnancy diagnostic test
kits. Following a trial in February 2008, the jury found that
the Company’s patents were valid and willfully infringed by Abbott during
the period from April 1999 through September 2003 and awarded damages to
the Company in the amount of $14.6 million. There are several
post-trial motions pending in the litigation seeking, among other things,
to set aside the verdict. These motions are pending, and the
Company will vigorously contest them. In June 2007, Abbott
filed suit against the Company claiming infringement of certain patents
that are licensed to Abbott, also in relation to pregnancy diagnostic test
kits. The Company intends to continue its vigorous defense of
this action.
|
g.
|
The
Company, in the ordinary course of its business, is the subject of, or a
party to, various pending or threatened legal actions. The
Company believes that any ultimate liability arising from these actions
will not have a material adverse effect on its financial
position.
|
12.
|
Related
Party Transactions
|
13.
|
Gain
on Sale of Business
|
14.
|
Segment
Information
|
Segment
|
Products
|
||
Consumer
Domestic
|
Household
and personal care products
|
||
Consumer
International
|
Primarily
personal care products
|
||
SPD
|
Specialty
chemical products
|
|
|
|||||||||||||||||||
(In
thousands)
|
Consumer
Domestic(3)
|
Consumer International(3) |
SPD
|
Corporate
|
Total
|
|||||||||||||||
Net Sales(1)
|
||||||||||||||||||||
First
Quarter 2008
|
$ | 382,744 | $ | 99,694 | $ | 70,429 | $ | - | $ | 552,867 | ||||||||||
First
Quarter 2007
|
$ | 369,834 | $ | 86,739 | $ | 57,762 | $ | - | $ | 514,335 | ||||||||||
Income before Minority Interest and
Income Taxes(2)
|
||||||||||||||||||||
First
Quarter 2008
|
$ | 67,831 | $ | 7,252 | $ | 9,941 | $ | 2,380 | $ | 87,404 | ||||||||||
First
Quarter 2007
|
$ | 52,765 | $ | 10,869 | $ | 4,527 | $ | 2,260 | $ | 70,421 |
(1)
|
Intersegment
sales from Consumer International to Consumer Domestic were $2.1 million
and $1.2 million for the three months ended March 28, 2008 and March 30,
2007, respectively.
|
(2)
|
In
determining Income Before Minority Interest and Income Taxes, interest
expense, investment earnings, and other income (expense)were allocated to
the segments based upon each segment’s relative operating profit. The
Corporate segment income consists of equity in earnings of
affiliates.
|
(3)
|
As
of January 1, 2008, the Company modified its organizational structure,
resulting in a change in classification of certain Consumer Domestic
export sales. Therefore, 2007 results have been restated to
reflect a change in sales of $2.5 million and $0.3 million of Income
Before Minority Interest that are now included in the Consumer
International Segment.
|
Three
Months Ended
|
||||||||
March
28,
|
March
30,
|
|||||||
(In thousands) |
2008
|
2007
|
||||||
Household
Products
|
$ | 242,827 | $ | 236,378 | ||||
Personal
Care Products
|
139,917 | 133,456 | ||||||
Total
Consumer Domestic
|
382,744 | 369,834 | ||||||
Total
Consumer International
|
99,694 | 86,739 | ||||||
Total
SPD
|
70,429 | 57,762 | ||||||
Total
Consolidated Net Sales
|
$ | 552,867 | $ | 514,335 |
For
the Three Months Ended March 28, 2008
|
||||||||||||||||||||
Guarantor
|
Non-Guarantor
|
Total
|
||||||||||||||||||
Parent
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Consolidated
|
||||||||||||||||
Net
Sales
|
$ | 445,352 | $ | 32,470 | $ | 117,507 | $ | (42,462 | ) | $ | 552,867 | |||||||||
Cost
of sales
|
288,239 | 13,695 | 69,289 | (42,462 | ) | 328,761 | ||||||||||||||
Gross
Profit
|
157,113 | 18,775 | 48,218 | - | 224,106 | |||||||||||||||
Marketing
expenses
|
41,970 | - | 11,515 | - | 53,485 | |||||||||||||||
Selling,
general and administrative expenses
|
46,812 | 5,541 | 25,505 | - | 77,858 | |||||||||||||||
Income
from Operations
|
68,331 | 13,234 | 11,198 | - | 92,763 | |||||||||||||||
Equity
in earnings of affiliates
|
24,421 | - | 1,880 | (23,921 | ) | 2,380 | ||||||||||||||
Investment
earnings
|
1,648 | 216 | 705 | - | 2,569 | |||||||||||||||
Intercompany
dividends/interest
|
(9,040 | ) | 10,030 | (990 | ) | - | - | |||||||||||||
Other
income (expense), net
|
1,361 | - | 837 | - | 2,198 | |||||||||||||||
Interest
expense
|
(11,085 | ) | - | (1,420 | ) | - | (12,505 | ) | ||||||||||||
Income before minority interest
and taxes
|
75,636 | 23,480 | 12,210 | (23,921 | ) | 87,405 | ||||||||||||||
Minority
interest
|
- | - | 3 | - | 3 | |||||||||||||||
Income
before income taxes
|
75,636 | 23,480 | 12,207 | (23,921 | ) | 87,402 | ||||||||||||||
Income
taxes
|
19,445 | 8,829 | 2,937 | - | 31,211 | |||||||||||||||
Net
Income
|
$ | 56,191 | $ | 14,651 | $ | 9,270 | $ | (23,921 | ) | $ | 56,191 |
For
the Three Months Ended March 30, 2007
|
||||||||||||||||||||
Guarantor
|
Non-Guarantor
|
Total
|
||||||||||||||||||
Parent
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Consolidated
|
||||||||||||||||
Net
Sales
|
$ | 426,275 | $ | 31,785 | $ | 98,984 | $ | (42,709 | ) | $ | 514,335 | |||||||||
Cost
of sales
|
285,399 | 13,416 | 58,353 | (42,709 | ) | 314,459 | ||||||||||||||
Gross
Profit
|
140,876 | 18,369 | 40,631 | - | 199,876 | |||||||||||||||
Marketing
expenses
|
35,868 | - | 9,984 | - | 45,852 | |||||||||||||||
Selling,
general and administrative expenses
|
52,696 | 3,646 | 15,539 | - | 71,881 | |||||||||||||||
Income
from Operations
|
52,312 | 14,723 | 15,108 | - | 82,143 | |||||||||||||||
Equity
in earnings of affiliates
|
32,864 | - | 1,687 | (32,291 | ) | 2,260 | ||||||||||||||
Investment
earnings
|
962 | 219 | 452 | - | 1,633 | |||||||||||||||
Intercompany
dividends/interest
|
(11,273 | ) | 8,922 | 2,351 | - | - | ||||||||||||||
Other
income (expense), net
|
56 | - | (470 | ) | - | (414 | ) | |||||||||||||
Interest
expense
|
(13,658 | ) | - | (1,543 | ) | - | (15,201 | ) | ||||||||||||
Income before minority interest
and taxes
|
61,263 | 23,864 | 17,585 | (32,291 | ) | 70,421 | ||||||||||||||
Minority
interest
|
- | - | (5 | ) | - | (5 | ) | |||||||||||||
Income
before income taxes
|
61,263 | 23,864 | 17,590 | (32,291 | ) | 70,426 | ||||||||||||||
Income
taxes
|
16,164 | 3,544 | 5,619 | - | 25,327 | |||||||||||||||
Net
Income
|
$ | 45,099 | $ | 20,320 | $ | 11,971 | $ | (32,291 | ) | $ | 45,099 |
March 28, 2008 | ||||||||||||||||||||
Guarantor
|
Non-Guarantor
|
Total
|
||||||||||||||||||
Parent
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Consolidated
|
||||||||||||||||
Assets
|
||||||||||||||||||||
Current
Assets
|
||||||||||||||||||||
Cash
and cash equivalents
|
$ | 116,161 | $ | 22,673 | $ | 69,228 | $ | - | $ | 208,062 | ||||||||||
Accounts
receivable, less allowances
|
2,561 | 1,014 | 239,938 | - | 243,513 | |||||||||||||||
Inventories
|
135,303 | 6,747 | 72,916 | - | 214,966 | |||||||||||||||
Deferred
income taxes
|
10,470 | - | 2,900 | - | 13,370 | |||||||||||||||
Note
receivable – current
|
1,324 | - | - | - | 1,324 | |||||||||||||||
Prepaid
expenses
|
7,076 | - | 4,478 | - | 11,554 | |||||||||||||||
Total
Current Assets
|
272,895 | 30,434 | 389,460 | - | 692,789 | |||||||||||||||
Property,
Plant and Equipment (Net)
|
245,776 | 42,982 | 51,050 | - | 339,808 | |||||||||||||||
Note
Receivable
|
2,342 | - | - | - | 2,342 | |||||||||||||||
Equity
Investments in Subsidiaries
|
627,272 | - | 8,380 | (626,089 | ) | 9,563 | ||||||||||||||
Long-term
Supply Contracts
|
2,323 | - | - | - | 2,323 | |||||||||||||||
Tradenames
and Other Intangibles
|
407,549 | 177,005 | 72,910 | - | 657,464 | |||||||||||||||
Goodwill
|
681,763 | - | 6,365 | - | 688,128 | |||||||||||||||
Other
Assets
|
89,916 | 352 | 10,611 | (28,014 | ) | 72,865 | ||||||||||||||
Total
Assets
|
$ | 2,329,836 | $ | 250,773 | $ | 538,776 | $ | (661,357 | ) | $ | 2,465,282 | |||||||||
Liabilities
and Stockholders' Equity
|
||||||||||||||||||||
Current
Liabilities
|
||||||||||||||||||||
Short-term
borrowings
|
$ | - | $ | - | $ | 15,293 | $ | - | $ | 15,293 | ||||||||||
Accounts
payable and accrued expenses
|
189,867 | 2,341 | 77,750 | - | 269,958 | |||||||||||||||
Current
portion of long-term debt
|
39,582 | - | - | - | 39,582 | |||||||||||||||
Due
to/from Subsidiaries
|
(9,021 | ) | (101,737 | ) | 139,983 | (29,225 | ) | - | ||||||||||||
Income
taxes payable
|
22,187 | - | 2,374 | - | 24,561 | |||||||||||||||
Total
Current Liabilities
|
242,615 | (99,396 | ) | 235,400 | (29,225 | ) | 349,394 | |||||||||||||
Long-term
Debt
|
692,982 | - | - | - | 692,982 | |||||||||||||||
Deferred
Income Taxes
|
146,217 | - | 14,935 | - | 161,152 | |||||||||||||||
Deferred
and Other Long Term Liabilities
|
90,481 | 95 | 2,939 | - | 93,515 | |||||||||||||||
Pension,
Postretirement and Postemployment Benefits
|
24,209 | - | 10,507 | - | 34,716 | |||||||||||||||
Minority
Interest
|
5 | - | 191 | - | 196 | |||||||||||||||
Commitments
and Contingencies
|
||||||||||||||||||||
Total
Liabilities
|
1,196,509 | (99,301 | ) | 263,972 | (29,225 | ) | 1,331,955 | |||||||||||||
Stockholders'
Equity
|
||||||||||||||||||||
Common
Stock-$1.00 par value
|
69,991 | 225,703 | 66,628 | (292,331 | ) | 69,991 | ||||||||||||||
Additional
paid-in capital
|
127,812 | 4,940 | 72,804 | (77,744 | ) | 127,812 | ||||||||||||||
Retained
earnings
|
942,752 | 119,431 | 94,375 | (213,806 | ) | 942,752 | ||||||||||||||
Accumulated
other comprehensive income (loss)
|
33,922 | - | 40,997 | (40,997 | ) | 33,922 | ||||||||||||||
1,174,477 | 350,074 | 274,804 | (624,878 | ) | 1,174,477 | |||||||||||||||
Common
stock in treasury, at cost:
|
(41,150 | ) | - | - | - | (41,150 | ) | |||||||||||||
Total
Stockholders’ Equity
|
1,133,327 | 350,074 | 274,804 | (624,878 | ) | 1,133,327 | ||||||||||||||
Total
Liabilities and Stockholders’ Equity
|
$ | 2,329,836 | $ | 250,773 | $ | 538,776 | $ | (661,357 | ) | $ | 2,465,282 |
December
31, 2007
|
||||||||||||||||||||
Guarantor
|
Non-Guarantor
|
Total
|
||||||||||||||||||
Parent
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Consolidated
|
||||||||||||||||
Assets
|
||||||||||||||||||||
Current
Assets
|
||||||||||||||||||||
Cash
and cash equivalents
|
$ | 150,783 | $ | 21,014 | $ | 78,012 | $ | - | $ | 249,809 | ||||||||||
Accounts
receivable, less allowances
|
1,471 | 2,113 | 244,314 | - | 247,898 | |||||||||||||||
Inventories
|
133,183 | 6,102 | 74,366 | - | 213,651 | |||||||||||||||
Deferred
income taxes
|
10,470 | - | 3,038 | - | 13,508 | |||||||||||||||
Note
receivable – current
|
1,263 | - | - | - | 1,263 | |||||||||||||||
Prepaid
expenses
|
6,085 | - | 3,139 | - | 9,224 | |||||||||||||||
Total
Current Assets
|
303,255 | 29,229 | 402,869 | - | 735,353 | |||||||||||||||
Property,
Plant and Equipment (Net)
|
248,292 | 42,887 | 59,674 | - | 350,853 | |||||||||||||||
Note
Receivable
|
3,666 | - | 4 | - | 3,670 | |||||||||||||||
Equity
Investments in Subsidiaries
|
620,837 | - | 8,911 | (619,424 | ) | 10,324 | ||||||||||||||
Long-term
Supply Contracts
|
2,519 | - | - | - | 2,519 | |||||||||||||||
Tradenames
and Other Intangibles
|
411,722 | 177,018 | 76,428 | - | 665,168 | |||||||||||||||
Goodwill
|
682,477 | - | 6,365 | - | 688,842 | |||||||||||||||
Other
Assets
|
89,438 | 368 | 12,904 | (26,949 | ) | 75,761 | ||||||||||||||
Total
Assets
|
$ | 2,362,206 | $ | 249,502 | $ | 567,155 | $ | (646,373 | ) | $ | 2,532,490 | |||||||||
Liabilities
and Stockholders' Equity
|
||||||||||||||||||||
Current
Liabilities
|
||||||||||||||||||||
Short-term
borrowings
|
$ | - | $ | - | $ | 115,000 | $ | - | $ | 115,000 | ||||||||||
Accounts
payable and accrued expenses
|
211,394 | 2,098 | 89,579 | - | 303,071 | |||||||||||||||
Current
portion of long-term debt
|
33,706 | - | - | - | 33,706 | |||||||||||||||
Due
to/from Subsidiaries
|
73,705 | (95,096 | ) | 49,629 | (28,238 | ) | - | |||||||||||||
Income
taxes payable
|
2,304 | - | 3,708 | - | 6,012 | |||||||||||||||
Total
Current Liabilities
|
321,109 | (92,998 | ) | 257,916 | (28,238 | ) | 457,789 | |||||||||||||
Long-term
Debt
|
707,311 | - | - | - | 707,311 | |||||||||||||||
Deferred
Income Taxes
|
144,216 | - | 18,530 | - | 162,746 | |||||||||||||||
Deferred
and Other Long Term Liabilities
|
84,799 | 76 | 2,894 | - | 87,769 | |||||||||||||||
Pension,
Postretirement and Postemployment Benefits
|
24,501 | - | 11,915 | - | 36,416 | |||||||||||||||
Minority
Interest
|
5 | - | 189 | - | 194 | |||||||||||||||
Commitments
and Contingencies
|
||||||||||||||||||||
Total
Liabilities
|
1,281,941 | (92,922 | ) | 291,444 | (28,238 | ) | 1,452,225 | |||||||||||||
Stockholders'
Equity
|
||||||||||||||||||||
Common
Stock-$1.00 par value
|
69,991 | 225,703 | 66,978 | (292,681 | ) | 69,991 | ||||||||||||||
Additional
paid-in capital
|
121,902 | 4,940 | 72,804 | (77,744 | ) | 121,902 | ||||||||||||||
Retained
earnings
|
891,868 | 111,781 | 91,699 | (203,480 | ) | 891,868 | ||||||||||||||
Accumulated
other comprehensive income (loss)
|
39,128 | - | 44,230 | (44,230 | ) | 39,128 | ||||||||||||||
1,122,889 | 342,424 | 275,711 | (618,135 | ) | 1,122,889 | |||||||||||||||
Common
stock in treasury, at cost:
|
(42,624 | ) | - | - | - | (42,624 | ) | |||||||||||||
Total
Stockholders’ Equity
|
1,080,265 | 342,424 | 275,711 | (618,135 | ) | 1,080,265 | ||||||||||||||
Total
Liabilities and Stockholders’ Equity
|
$ | 2,362,206 | $ | 249,502 | $ | 567,155 | $ | (646,373 | ) | $ | 2,532,490 |
For the Three Months Ended March 28, 2008 | ||||||||||||||||||||
Guarantor
|
Non-Guarantor
|
Total
|
||||||||||||||||||
Parent
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Consolidated
|
||||||||||||||||
Cash
Flow From Operating Activities
|
||||||||||||||||||||
Net
Income
|
$ | 56,191 | $ | 14,651 | $ | 9,270 | $ | (23,921 | ) | $ | 56,191 | |||||||||
Adjustments
to reconcile net income to net cash provided
by operating activities:
|
||||||||||||||||||||
Depreciation
and amortization
|
12,056 | 962 | 2,194 | - | 15,212 | |||||||||||||||
Equity
in earnings of affiliates
|
(24,423 | ) | - | (1,878 | ) | 23,921 | (2,380 | ) | ||||||||||||
Distributions
from unconsolidated affiliates
|
9,064 | - | 1,832 | (8,332 | ) | 2,564 | ||||||||||||||
Deferred
income taxes
|
3,055 | - | (952 | ) | - | 2,103 | ||||||||||||||
Gain
on sale of subsidiary
|
(3,005 | ) |
-
|
-
|
-
|
(3,005 | ) | |||||||||||||
Asset
impairment charges and other asset write-offs
|
4 | - | 5,622 | - | 5,626 | |||||||||||||||
Non
cash compensation expense
|
2,424 | - | - | - | 2,424 | |||||||||||||||
Unrealized
foreign exchange gain and other
|
(1,099 | ) | - | (1,459 | ) | - | (2,558 | ) | ||||||||||||
Change
in assets and liabilities:
|
||||||||||||||||||||
Accounts
receivable
|
(1,090 | ) | 1,099 | 3,427 | - | 3,436 | ||||||||||||||
Inventories
|
(2,120 | ) | (645 | ) | (784 | ) | - | (3,549 | ) | |||||||||||
Prepaid
expenses
|
(991 | ) | - | (1,418 | ) | - | (2,409 | ) | ||||||||||||
Accounts
payable and accrued expenses
|
(21,426 | ) | 243 | (9,290 | ) | - | (30,473 | ) | ||||||||||||
Income
taxes payable
|
22,966 | - | (2,030 | ) | - | 20,936 | ||||||||||||||
Excess
tax benefit on stock options exercised
|
(1,872 | ) | - | - | - | (1,872 | ) | |||||||||||||
Intercompany
activity
|
(81,143 | ) | (6,626 | ) | 87,769 | - | - | |||||||||||||
Other
liabilities
|
458 | 19 | - | - | 477 | |||||||||||||||
Net
Cash Provided By (Used In) Operating Activities
|
(30,951 | ) | 9,703 | 92,303 | (8,332 | ) | 62,723 | |||||||||||||
Cash
Flow From Investing Activities
|
||||||||||||||||||||
Additions
to property, plant and equipment
|
(4,520 | ) | (1,044 | ) | (719 | ) | - | (6,283 | ) | |||||||||||
Net
proceeds from assets
|
9,620 |
-
|
-
|
-
|
9,620 | |||||||||||||||
Proceeds
from note receivable
|
1,263 | - | - | - | 1,263 | |||||||||||||||
Contingent
acquisition payments
|
(305 | ) | - | - | - | (305 | ) | |||||||||||||
Other
|
(602 | ) | - | 491 | - | (111 | ) | |||||||||||||
Net
Cash (Used In) Provided By Investing Activities
|
5,456 | (1,044 | ) | (228 | ) | - | 4,184 | |||||||||||||
Cash
Flow From Financing Activities
|
||||||||||||||||||||
Long-term
debt repayment
|
(8,453 | ) | - | - | - | (8,453 | ) | |||||||||||||
Short-term
debt (repayments) borrowings - net
|
- | - | (100,000 | ) | - | (100,000 | ) | |||||||||||||
Bank
overdrafts
|
- | - | 293 | - | 293 | |||||||||||||||
Proceeds
from stock options exercised
|
2,761 | - | - | - | 2,761 | |||||||||||||||
Excess
tax benefit on stock options exercised
|
1,872 | - | - | - | 1,872 | |||||||||||||||
Payment
of cash dividends
|
(5,307 | ) | (7,000 | ) | (1,332 | ) | 8,332 | (5,307 | ) | |||||||||||
Net
Cash (Used In) Provided by Financing Activities
|
(9,127 | ) | (7,000 | ) | (101,039 | ) | 8,332 | (108,834 | ) | |||||||||||
Effect
of exchange rate changes on cash and cash equivalents
|
- | - | 180 | - | 180 | |||||||||||||||
Net
Change in Cash and Cash Equivalents
|
(34,622 | ) | 1,659 | (8,784 | ) | - | (41,747 | ) | ||||||||||||
Cash
and Cash Equivalents at Beginning Of Period
|
150,783 | 21,014 | 78,012 | - | 249,809 | |||||||||||||||
Cash
and Cash Equivalents at End Of Period
|
$ | 116,161 | $ | 22,673 | $ | 69,228 | $ | - | $ | 208,062 |
For the Three Months Ended March 30, 2007 | ||||||||||||||||||||
Guarantor
|
Non-Guarantor
|
Total
|
||||||||||||||||||
Parent
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Consolidated
|
||||||||||||||||
Cash
Flow From Operating Activities
|
||||||||||||||||||||
Net
Income
|
$ | 45,099 | $ | 20,320 | $ | 11,971 | $ | (32,291 | ) | $ | 45,099 | |||||||||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||||||||||||||
Depreciation
and amortization
|
11,937 | 884 | 1,793 | - | 14,614 | |||||||||||||||
Equity
in earnings of affiliates
|
(32,863 | ) | - | (1,688 | ) | 32,291 | (2,260 | ) | ||||||||||||
Distributions
from unconsolidated affiliates
|
7,461 | - | 1,219 | (7,219 | ) | 1,461 | ||||||||||||||
Deferred
income taxes
|
3,782 | - | 314 | - | 4,096 | |||||||||||||||
Asset
impairment charges and other asset write-offs
|
211 | 361 | 23 | - | 595 | |||||||||||||||
Non
cash compensation expense
|
2,819 | - | - | - | 2,819 | |||||||||||||||
Unrealized
foreign exchange gain
|
658 | - | (482 | ) | - | 176 | ||||||||||||||
Change
in assets and liabilities:
|
||||||||||||||||||||
Accounts
receivable
|
3,344 | (68 | ) | (1,093 | ) | - | 2,183 | |||||||||||||
Inventories
|
(16,525 | ) | (207 | ) | (3,444 | ) | - | (20,176 | ) | |||||||||||
Prepaid
expenses
|
(1,531 | ) | - | (686 | ) | - | (2,217 | ) | ||||||||||||
Accounts
payable and accrued expenses
|
(23,387 | ) | (79 | ) | (7,090 | ) | - | (30,556 | ) | |||||||||||
Income
taxes payable
|
15,449 | (301 | ) | (602 | ) | - | 14,546 | |||||||||||||
Excess
tax benefit on stock options exercised
|
(3,837 | ) | - | - | - | (3,837 | ) | |||||||||||||
Intercompany
activity
|
43,916 | (12,424 | ) | (31,492 | ) | - | - | |||||||||||||
Other
liabilities
|
2,860 | 25 | 172 | - | 3,057 | |||||||||||||||
Net
Cash Provided By (Used In) Operating Activities
|
59,393 | 8,511 | (31,085 | ) | (7,219 | ) | 29,600 | |||||||||||||
Cash
Flow From Investing Activities
|
||||||||||||||||||||
Additions
to property, plant and equipment
|
(8,666 | ) | (1,365 | ) | (1,263 | ) | - | (11,294 | ) | |||||||||||
Acquisitions
(net of cash acquired)
|
(181 | ) | - | - | - | (181 | ) | |||||||||||||
Return
of capital from equity affiliates
|
150 | - | 150 | (150 | ) | 150 | ||||||||||||||
Contingent
acquisition payments
|
(370 | ) | - | - | - | (370 | ) | |||||||||||||
Other
|
113 | 41 | (2 | ) | - | 152 | ||||||||||||||
Net
Cash Used In Investing Activities
|
(8,954 | ) | (1,324 | ) | (1,115 | ) | (150 | ) | (11,543 | ) | ||||||||||
Cash
Flow From Financing Activities
|
||||||||||||||||||||
Long-term
debt repayment
|
(39,537 | ) | - | - | - | (39,537 | ) | |||||||||||||
Short-term
debt (repayments) borrowings - net
|
(40 | ) | - | 15,051 | - | 15,011 | ||||||||||||||
Bank
overdrafts
|
(1,939 | ) | - | - | - | (1,939 | ) | |||||||||||||
Proceeds
from stock options exercised
|
6,445 | - | - | - | 6,445 | |||||||||||||||
Excess
tax benefit on stock options exercised
|
3,837 | - | - | - | 3,837 | |||||||||||||||
Payment
of cash dividends
|
(4,584 | ) | (6,000 | ) | (1,369 | ) | 7,369 | (4,584 | ) | |||||||||||
Net
Cash (Used In) Provided by Financing Activities
|
(35,818 | ) | (6,000 | ) | 13,682 | 7,369 | (20,767 | ) | ||||||||||||
Effect
of exchange rate changes on cash and cash equivalents
|
- | - | (28 | ) | - | (28 | ) | |||||||||||||
Net
Change in Cash and Cash Equivalents
|
14,621 | 1,187 | (18,546 | ) | - | (2,738 | ) | |||||||||||||
Cash
and Cash Equivalents at Beginning Of Period
|
22,111 | 20,302 | 68,063 | - | 110,476 | |||||||||||||||
Cash
and Cash Equivalents at End Of Period
|
$ | 36,732 | $ | 21,489 | $ | 49,517 | $ | - | $ | 107,738 |
15.
|
Subsequent
Event
|
ITEM
2.
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS
|
Segment
|
Products
|
Consumer
Domestic
|
Household
and personal care products
|
Consumer
International
|
Primarily
personal care products
|
SPD
|
Specialty
chemical products
|
(In
thousands)
|
Consumer
Domestic(3)
|
Consumer
International(3)
|
SPD
|
Corporate
|
Total
|
|||||||||||||||
Net Sales(1)
|
||||||||||||||||||||
First Quarter 2008
|
$
|
382,744
|
$
|
99,694
|
$
|
70,429
|
$
|
-
|
$
|
552,867
|
||||||||||
First
Quarter 2007
|
$
|
369,834
|
$
|
86,739
|
$
|
57,762
|
$
|
-
|
$
|
514,335
|
||||||||||
Income before Minority Interest and Income
Taxes(2)
|
||||||||||||||||||||
First
Quarter 2008
|
$
|
67,831
|
$
|
7,252
|
$
|
9,941
|
$
|
2,380
|
$
|
87,404
|
||||||||||
First
Quarter 2007
|
$
|
52,765
|
$
|
10,869
|
$
|
4,527
|
$
|
2,260
|
$
|
70,421
|
(1)
|
Intersegment
sales from Consumer International to Consumer Domestic were $2.1 million
and $1.2 million for the three months ended March 28, 2008 and March 30,
2007, respectively.
|
(2)
|
In
determining Income Before Minority Interest and Income Taxes, interest
expense, investment earnings, and other income (expense) were allocated to
the segments based upon each segment’s relative operating profit. The
Corporate segment income consists of equity in earnings of
affiliates.
|
(3)
|
As
of January 1, 2008, the Company modified its organizational structure,
resulting in a change in classification of certain Consumer Domestic
export sales. Therefore, 2007 results have been restated to
reflect a change in sales of $2.5 million and $0.3 million of Income
Before Minority Interest that are now included in the Consumer
International Segment.
|
Three Months
Ended
|
||||||||
March
28,
|
March
30,
|
|||||||
(In thousands) |
2008
|
2007
|
||||||
Household
Products
|
$ | 242,827 | $ | 236,378 | ||||
Personal
Care Products
|
139,917 | 133,456 | ||||||
Total
Consumer Domestic
|
382,744 | 369,834 | ||||||
Total
Consumer International
|
99,694 | 86,739 | ||||||
Total
SPD
|
70,429 | 57,762 | ||||||
Total
Consolidated Net Sales
|
$ | 552,867 | $ | 514,335 |
Three
Months Ended
|
||||||||
Cash Flow Analysis (In
millions)
|
March
28, 2008
|
March
30, 2007
|
||||||
Net
Cash Provided by Operating Activities
|
$ | 62.7 | $ | 29.6 | ||||
Net
Cash Provided by (Used in) Investing Activities
|
$ | 4.2 | $ | (11.5 | ) | |||
Net
Cash Used in Financing Activities
|
$ | (108.8 | ) | $ | (20.8 | ) |
|
Accounts
receivable decreased $3.4 million due to decreases at certain foreign
subsidiaries.
|
|
Inventories
increased $3.5 million primarily to support higher anticipated sales.
|
|
Accounts
payable and other accrued expenses decreased $30.5 million primarily due
to incentive compensation and profit sharing
payments.
|
|
Taxes
payable increased $20.9 million due to higher tax expense associated with
higher earnings.
|
Net
Cash Provided by Operating Activities
|
$ | 62.7 | ||
Interest
Expense
|
12.5 | |||
Current
Portion Of Income Tax Provision
|
29.1 | |||
Tax
Benefit On Stock Options Exercised
|
1.9 | |||
Change
in Working Capital and Other Liabilities
|
11.6 | |||
Investment
Income
|
(2.6 | ) | ||
Other | 1.9 | |||
Adjusted
EBITDA (per loan agreement)
|
$ | 117.1 |
ITEM
3.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURE ABOUT MARKET
RISK
|
ITEM
4.
|
CONTROLS
AND PROCEDURES
|
Nominees
|
For
|
Withheld
|
||||||
James
R. Craigie
|
56,687,171 | 845,196 | ||||||
Robert
A. Davies, III
|
56,525,701 | 1,006,666 | ||||||
Rosina
B. Dixon, M.D.
|
56,555,016 | 977,351 | ||||||
Robert
D. Leblanc
|
56,887,396 | 644,971 |
For
|
Against
|
Abstain
|
||
50,723,448
|
6,614,912
|
194,006
|
For
|
Against
|
Abstain
|
Broker Non-votes
|
|||
45,448,525
|
4,342,298
|
230,666
|
7,510,878
|
For
|
Against
|
Abstain
|
||
56,846,642
|
654,126
|
31,599
|
(3.1)
|
Restated
Certificate of Incorporation of the Company, as amended through May 9,
2005 – incorporated by reference to Exhibit 3.2 to the Company’s quarterly
report on Form 10-Q for the quarter ended April 1,
2005.
|
|
(3.2)
|
By-laws
of the Company as amended – incorporated by reference to Exhibit 3.1 to
the Company’s current report on Form 8-K dated November 5,
2007.
|
|
(10.1)
|
Church
& Dwight Co., Inc. Omnibus Equity Compensation Plan, incorporated by
reference to the Company's definitive Proxy Statement, dated March 31,
2008.
|
|
• |
(10.2)
|
Form
of Nonqualified Stock Option Grant for Employees pursuant to the Church
& Dwight Co., Inc. Omnibus
Equity Compensation Plan.
|
• |
(10.3)
|
Form
of Nonqualified Stock Option Grant for Directors pursuant to the Church
& Dwight Co., Inc. Omnibus
Equity Compensation Plan.
|
• | (10.4) | Compensation Plan for Directors, amended and restated effective May 1, 2008. |
• | (10.5) | Deferred Compensation Plan for Directors, amended and restated effective May 1, 2008. |
• |
(11)
|
Computation
of earnings per share.
|
• |
(31.1)
|
Certification
of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
• |
(31.2)
|
Certification
of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
• |
(32.1)
|
Certification
of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b)
under the Exchange Act and 18 U.S.C. Section 1350.
|
• |
(32.2)
|
Certification of the
Chief Financial Officer of the Company pursuant to Rule 13a-14(b) under
the Exchange Act and 18 U.S.C. Section 1350.
|
•
|
Indicates
documents filed herewith.
|
CHURCH & DWIGHT CO.,
INC.
|
|||
(REGISTRANT)
|
|||
DATE:
|
May
6, 2008
|
/s/
Matthew T. Farrell
|
|
MATTHEW
T. FARRELL
|
|||
CHIEF
FINANCIAL OFFICER
|
|||
DATE:
|
May
6, 2008
|
/s/
Steven J. Katz
|
|
STEVEN
J. KATZ
|
|||
VICE
PRESIDENT AND
|
|||
CONTROLLER
|
|||
(PRINCIPAL
ACCOUNTING OFFICER)
|
(3.1)
|
Restated Certificate
of Incorporation of the Company, as amended through May 9, 2005 –
incorporated by reference
to Exhibit 3.2 to the Company’s quarterly report on Form 10-Q for the
quarter ended April 1, 2005.
|
|
(3.2)
|
By-laws of the
Company as amended – incorporated by reference to Exhibit 3.1 to the
Company’s current report on Form
8-K dated November 5, 2007.
|
|
(10.1)
|
Church
& Dwight Co., Inc. Omnibus Equity Compensation Plan, incorporated
by reference to the Company's definitive Proxy Statement, dated March 31,
2008.
|
|
• |
(10.2)
|
Form
of Nonqualified Stock Option Grant for Employees pursuant to the Church
& Dwight Co., Inc. Omnibus
Equity Compensation Plan.
|
• |
(10.3)
|
Form
of Nonqualified Stock Option Grant for Directors pursuant to the Church
& Dwight Co., Inc. Omnibus
Equity Compensation Plan.
|
• | (10.4) | Compensation Plan for Directors, amended and restated effective May 1, 2008. |
• |
(10.5)
|
Deferred Compensation Plan for Directors, amended and restated effective May 1, 2008. |
• |
(11)
|
Computation
of earnings per share.
|
• |
(31.1)
|
Certification
of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
• |
(31.2)
|
Certification
of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
• |
(32.1)
|
Certification of the
Chief Executive Officer of the Company pursuant to Rule 13a-14(b) under
the Exchange
Act and 18 U.S.C. Section 1350.
|
• |
(32.2)
|
Certification of the
Chief Financial Officer of the Company pursuant to Rule 13a-14(b)
under the Exchange
Act and 18 U.S.C. Section 1350.
|
|
||
•
|
Indicates
documents filed herewith.
|